1 |
Pelis K. Blood clots: the nineteenth-century debate over the substance and means of transfusion in Britain. Ann Sci 1997;54:331-60.
DOI
ScienceOn
|
2 |
Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003;43:668-76.
DOI
ScienceOn
|
3 |
Boldt J, Weber A, Mailer K, Papsdorf M, Schuster P. Acute normovolaemic haemodilution vs controlled hypotension for reducing the use of allogeneic blood in patients undergoing radical prostatectomy. Br J Anaesth 1999;82:170-4.
DOI
ScienceOn
|
4 |
Schonhofer B, Wenzel M, Geibel M, Haidl P, Kohler D. Anemia increases work of breathing in patients with lung disease. Med Klin (Munich) 1997;92 Suppl 1:108-10.
|
5 |
Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003;361:161-9.
DOI
ScienceOn
|
6 |
Corwin HL. Blood transfusion: first, do no harm! Chest 1999; 116:1149-50.
DOI
ScienceOn
|
7 |
Goodnough LT, Monk TG, Brecher ME. Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurement. Transfusion 1998;38:473-6.
DOI
ScienceOn
|
8 |
Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 2000;93:242-55.
DOI
ScienceOn
|
9 |
Doyle DJ. Blood transfusions and the Jehovah's Witness patient. Am J Ther 2002;9:417-24.
DOI
ScienceOn
|
10 |
Sacks DA, Koppes RH. Blood transfusion and Jehovah's Witnesses: medical and legal issues in obstetrics and gynecology. Am J Obstet Gynecol 1986;154:483-6.
DOI
|
11 |
Marsh JC, Bevan DH. Haematological care of the Jehovah's Witness patient. Br J Haematol 2002;119:25-37.
DOI
ScienceOn
|
12 |
Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 1990;115:28-35.
|
13 |
Goodnough LT, Verbrugge D, Marcus RE, Goldberg V. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation. J Am Coll Surg 1994;179:171-6.
|
14 |
Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000;96:823-33.
|
15 |
Coleman TR, Westenfelder C, Togel FE, Yang Y, Hu Z, Swenson L, et al. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci U S A 2006;103:5965-70.
DOI
ScienceOn
|
16 |
Levy JH, Bailey JM, Salmenpera M. Pharmacokinetics of aprotinin in preoperative cardiac surgical patients. Anesthesiology 1994;80:1013-8.
DOI
ScienceOn
|
17 |
Riess JG. Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 2006;34:567-80.
DOI
ScienceOn
|
18 |
Jaskolka M. Politano N, Lewallen B, White R, Phillips C. The impact of preoperative erythropoietin on recovery after orthognathic surgery. J Oral Maxillofac Surg 2010;68(9 Suppl 1):9-10.
DOI
|
19 |
Politano NA. Jaskolka M, Lewallen B, White R, Phillips C. The effect of preoperative recombinant erythropoietin and type of surgical procedure on postoperative hematocrit following orthognathic surgery. J Oral Maxillofac Surg 2009;67(9 Suppl 1):28-9.
DOI
|